OpenNeedle Ask your own

Question explored with the scientific record

Answered on this page ↓

Were there any studies that re-exposed ferrets at 3–12 months post-dose?

Oct 2, 2026 · 3 sources used · OpenNeedle synthesis
The short version: no ferret study in this retrieval rechallenged animals months after vaccination to test durable protection.

The single ferret COVID-19 vaccine study here challenged animals just 3 weeks after the booster dose and measured viral clearance only at 7 and 14 days post-challenge [1]. That is a short-term efficacy window, not a test of protection that lasts months. The study never brought the ferrets back for a second challenge later.

The broader animal evidence in this retrieval shows the same gap. A SARS-CoV vaccine study in ferrets using a modified vaccinia vector (MVA-S) found that neutralizing antibody responses were not protective and produced strong antibody-dependent enhancement effects [2], but that study also did not rechallenge after a delay. The rhesus macaque study that did rechallenge at 28 days post-infection found full protection [3], but that is a different species, a natural infection model, and still only a one-month interval.

No record here tested what happens when a vaccinated ferret faces the virus again 3, 6, or 12 months later. That is the design that would tell you whether protection wanes, holds, or turns harmful over time. It was not run.

My call: the evidence does not answer whether ferrets remain protected months after COVID-19 vaccination. Confidence: low, because the question was never tested in the studies retrieved.

Keep digging

Sources used 3

  1. Routine SARS‐CoV ‐2 vaccination for all children* Immunological Reviews (2022) narrative review Strong

    The authors argue the benefits of routine SARS-CoV-2 vaccination outweigh the risks for all children and recommend adding it to the routine pediatric vaccine schedule worldwide.

    DOI: 10.1111/imr.13108
  2. Leukocyte Count in Solid Organ Transplant Recipients After SARS-CoV-2 mRNA Vaccination and Infection Vaccines (2025) Thin

    This study investigates the impact of SARS-CoV-2 mRNA vaccination and infection on leukocyte counts in solid organ transplant recipients, finding no association between vaccination and decreased leukocyte counts, while infection significantly increased the risk of leukopenia.

    DOI: 10.3390/vaccines13020103
  3. Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine Virologica Sinica (2018) Thin

    This study evaluates the potential for antibody-dependent enhancement (ADE) of SARS-CoV infection in rhesus macaques immunized with an inactivated SARS-CoV vaccine, finding no evidence of ADE and suggesting the vaccine's safety for clinical trials.

    DOI: 10.1007/s12250-018-0009-2

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →